logo
Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

Business Wire4 days ago
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the Centers for Medicare and Medicaid Services (CMS), through the MolDX program, has issued preliminary gapfill payment rates of $350 for Epi+Gen CHD™ and $684.76 for PrecisionCHD™. A 'gapfill' payment rate means that pricing is determined by each Medicare contractor, including MolDX, based on cost data from Cardio Diagnostics.
These preliminary payment rates, proposed as part of the calendar year 2025 gapfill pricing process, are expected to be finalized later this year and will be effective for claims with dates of service on or after January 1, 2025. The proposed rates represent a significant positive development in the Company's efforts to expand access to its advanced cardiovascular testing for Medicare beneficiaries.
'We view this as a critical step toward expanding timely access and improving care for Medicare patients' said Meesha Dogan, PhD., CEO and Co-Founder of Cardio Diagnostics. 'Many Medicare beneficiaries, who are at elevated risk for coronary heart disease, go undetected and undertreated, often resulting in avoidable heart attacks, hospitalizations, and poor outcomes.'
Cardio Diagnostics clarified during a recent meeting with MolDX that initial public documentation had inadvertently transposed the pricing between the two tests, and MolDX confirmed the correct association of the proposed payment rates to their respective tests.
Addressing the Leading Cause of Death
Cardiovascular disease remains the leading cause of death in the United States, particularly among Americans aged 65 and older. In 2022 alone, over 700,000 Americans died from heart disease, with coronary heart disease (CHD) accounting for more than 370,000 deaths.
PrecisionCHD™ is a groundbreaking AI-powered test designed to aid in the diagnosis of CHD by analyzing both genetic and epigenetic markers. Meanwhile, Epi+Gen CHD™ provides insight into a patient's three-year risk for a CHD event, such as a heart attack. Both tests are performed from a simple blood draw, enabling scalable, accessible, and non-invasive cardiovascular assessment. Both tests received dedicated CPT Proprietary Laboratory Analysis (PLA) codes from the American Medical Association, 0439U for Epi+Gen CHD and 0440U for PrecisionCHD, that were effective on April 1, 2024.
About Cardio Diagnostics
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ('Core Technology') for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit https://cdio.ai/.
Forward-Looking Statements
Certain statements and information included in this press release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases 'will', 'will likely result,' 'expected to,' 'will continue,' 'anticipated,' 'estimate,' 'projected,' 'intend,' 'goal,' or similar expressions are intended to identify 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, and dependence on results as discussed in the Annual Report on Form 10-K for the period ended December 31, 2024, under the heading 'Risk Factors' in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Weiss Memorial Hospital's access to Medicare payments revoked, IDPH announced
Weiss Memorial Hospital's access to Medicare payments revoked, IDPH announced

CBS News

time3 hours ago

  • CBS News

Weiss Memorial Hospital's access to Medicare payments revoked, IDPH announced

The future of Weiss Memorial Hospital in Uptown is uncertain after the federal Department of Health and Human Services announced that it is revoking the facility's ability to receive Medicare payments. Starting on Aug. 9, Medicare won't pay Weiss for inpatient services. The move could be devastating for the safety-net hospital, which the Sun-Times reported received over half of its 2023 revenue from the program. While the notice didn't elaborate on why it deemed Weiss not "compliant" with its guidelines, the hospital's air-conditioning system failed last month, forcing dozens of patients to be transferred to its sister institution, West Suburban Hospital in Oak Park. Since then, Weiss has rendered only limited services to patients while it awaits spare parts to fix the air conditioning. In a statement, a spokesperson for the Illinois Department of Public Health said: "The Illinois Department of Public Health has been closely monitoring the situation at Weiss Memorial Hospital. As required by law, the results of our surveys of the hospital are shared with the federal Center for Medicare and Medicaid Services (CMS). CMS holds the authority to and made the decision to terminate Weiss's involvement with the Medicare program effective August 9, 2025. There is a process for reconsideration that Weiss can pursue. IDPH is committed to ensuring patient safety and quality of care at healthcare facilities in Illinois and will engage with Weiss as appropriate."

New tool can remove nearly all of a cancer-causing ‘forever chemical' from water — in just 5 minutes
New tool can remove nearly all of a cancer-causing ‘forever chemical' from water — in just 5 minutes

New York Post

time4 hours ago

  • New York Post

New tool can remove nearly all of a cancer-causing ‘forever chemical' from water — in just 5 minutes

Your tap water's dirty little secret might have just met its match. Scientists have engineered a high-tech filter that strips toxic 'forever chemicals' from drinking water in a matter of minutes. Better yet, the new tool glows on contact with contamination, serving as both a purifier and an real-time monitoring system. 4 Research suggests the majority of Americans have 'forever chemicals' in their drinking water. sebra – Forever chemicals — officially known as per- and poly-fluoroalkyl substances (PFAS) — are tiny, man-made compounds that break down very slowly and accumulate in people, animals and the environment over time. They've been used since the 1940s in everything from non-stick cookware and grease-resistant food packaging to waterproof fabrics and personal care products. But concerns are mounting over the potential health effects of PFAS, with some experts likening them to 'slow poison.' One of the most widely used forever chemicals, perfluorooctanoic acid (PFOA), has been linked to higher risks of certain cancers, liver damage, immune system issues, high cholesterol and even developmental delays in fetuses and children. It has been detected across a range of environments and products — from soil and rainfall to seafood, human blood and drinking water. 4 While PFOA was previously used in the manufacturing of non-stock cookware, it has largely been phased out due to concerns about potential health and environmental risks. Dina – In fact, a 2020 study estimated that more than 200 million Americans are drinking water contaminated with PFOA or PFOS, another notorious forever chemical formally known as perfluorooctane sulfonate. Now, researchers at the University of Utah may have found a way to help reduce that exposure. The scientists recently developed a lab-engineered, crystalline substance known as a metal-organic framework (MOF) that functions like a molecular sieve. When water flows through the material, it snags and traps PFOA molecules, effectively removing the forever chemical. 4 The work builds on past research from the team that created a porous material that fluoresces in the presence of PFAS. THE UNIVERSITY OF UTAH In lab tests, the MOF cleared out more than 99% of the toxic substance in just five minutes. 'This sort of rapid treatment is crucial for real-world applications,' the study authors wrote in their report. The material also worked in the presence of other PFAS compounds, salts, and natural organic matter found in drinking water supplies, suggesting it could perform well in a variety of real-world environmental conditions. Better yet, the MOF can be reused, with researchers finding it retained 93% of its adsorption efficiency after five wash cycles. That's a big deal, since current methods for removing PFAS are often slow, costly, inefficient and don't hold up well after repeated use. 4 PFAS in drinking water are estimated to contribute to more than 6,800 cancer cases each year. WESTOCK – An added bonus: when PFOA molecules bind to the material, it glows fluorescent — providing instant, on-the-spot confirmation of contamination. 'This MOF represents a major leap forward for PFAS remediation,' Rana Dalapati, the study's lead author, said in a statement. 'Its ability to both selectively capture and sensitively detect PFOA in real time makes it a versatile and practical solution for water treatment and environmental monitoring,' she added. Looking ahead, the team believes this material could one day be adapted to capture other PFAS chemicals, not just PFOA. Wondering if you should be concerned about forever chemicals in your drinking water? The Environmental Working Group's Tap Water Database is a good place to start — just enter your ZIP code to see what's in your local supply. While the newly developed MOF may one day offer a powerful solution, it will likely be a while before it's available for public use. In the meantime, if you live in an area with known PFAS contamination, consider getting a water filter. Look for one certified by the National Sanitation Foundation to reduce levels of PFOA and PFOS to help limit your exposure.

Are 2 to 3 cups of coffee a day too much? It's complicated, experts say: 'It's different for each person'
Are 2 to 3 cups of coffee a day too much? It's complicated, experts say: 'It's different for each person'

CNBC

time5 hours ago

  • CNBC

Are 2 to 3 cups of coffee a day too much? It's complicated, experts say: 'It's different for each person'

Two-thirds of Americans drink coffee every single day, according to data collected by the National Coffee Association in 2022, and the debate about how much is too much and whether or not any amount of caffeine is safe persists. But recent research shows that the answer is more complicated than you'd think. A Harvard study, that followed nearly 50,000 women over the course of 30 years and published in June, found that drinking coffee every day may lead to healthy aging in women. One to three cups a day was also linked to heart health benefits and lower mortality rates. But research also shows that high coffee consumption can increase your likelihood of dementia. And a 2022 paper published in the Journal of the American Heart Association found a link between heavy coffee consumption and an increased risk of dying from cardiovascular disease in people with hypertension. Benefits, drawbacks, and the right amount all depend on your individual lifestyle and overall health. And health experts consistently advise that, like with most things, moderation is key for your daily coffee. Deepak Chopra, author, speaker and proponent of alternative medicine, told CNBC Make It in 2023 that he drinks two to three cups of coffee each day before noon. While that may sound like too much caffeine for the average person, it's actually within a healthy range. "Drinking two to three cups before noon is safe to do," registered dietitian Roxana Ehsani said in an interview with CNBC Make It last year. "As long as they don't greatly surpass 400 milligrams of caffeine." Ehsani's suggestion follows the Food and Drug Administration's recommendation of consuming no more than 400 milligrams of caffeine a day, which can include the caffeine found in teas, energy drinks, sodas and chocolate. Certain people may benefit from consuming much less caffeine than is recommended by the FDA. Caffeine tolerance varies from person to person, with some people feeling anxious or jittery after just one or two cups of coffee. "Within those milligram or cup of coffee recommendations, if you start feeling overly tired and the caffeine is not helping, then you've got to stop [drinking it]," dietitian Jessica Sylvester told NBC News. "If your heart starts beating incredibly fast, you've got to stop. It's different for each person." Pregnant people should consider cutting back on caffeine. And people who have diabetes or cardiovascular disease should be mindful of their sugar intake when having coffee, Nikki Cota, a dietitian at the Mayo Clinic, told NBC News. Expert opinion also varies on if teens should drink coffee, but "avoiding caffeine is the best choice for all kids," according to the American Academy of Pediatrics. But for everyone else, if you're having two to three cups, or more, "be mindful of what you're experiencing," registered dietitian Maddie Pasquariello says. And make sure you're not replacing meals with caffeine. Ehsani recommends drinking water or having a meal before reaching for coffee since caffeine suppresses appetite. And if you notice your sleep is affected when you have a coffee in the afternoon, experts suggest a mornings-only rule for your daily latte or macchiato.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store